nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Hypoxemia—Vinorelbine—ovarian cancer	0.0932	0.0932	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Vinorelbine—ovarian cancer	0.0294	0.0294	CcSEcCtD
Cisatracurium Besylate—Convulsion—Altretamine—ovarian cancer	0.0262	0.0262	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Topotecan—ovarian cancer	0.0164	0.0164	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Topotecan—ovarian cancer	0.0151	0.0151	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Melphalan—ovarian cancer	0.0148	0.0148	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Melphalan—ovarian cancer	0.0132	0.0132	CcSEcCtD
Cisatracurium Besylate—Wheezing—Paclitaxel—ovarian cancer	0.0122	0.0122	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Vinorelbine—ovarian cancer	0.012	0.012	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Vinorelbine—ovarian cancer	0.0115	0.0115	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Melphalan—ovarian cancer	0.0106	0.0106	CcSEcCtD
Cisatracurium Besylate—Flushing—Melphalan—ovarian cancer	0.00997	0.00997	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Topotecan—ovarian cancer	0.00996	0.00996	CcSEcCtD
Cisatracurium Besylate—Injury—Paclitaxel—ovarian cancer	0.00993	0.00993	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Topotecan—ovarian cancer	0.00991	0.00991	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Topotecan—ovarian cancer	0.00989	0.00989	CcSEcCtD
Cisatracurium Besylate—Angioedema—Chlorambucil—ovarian cancer	0.00981	0.00981	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Melphalan—ovarian cancer	0.00971	0.00971	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Melphalan—ovarian cancer	0.00969	0.00969	CcSEcCtD
Cisatracurium Besylate—Convulsion—Chlorambucil—ovarian cancer	0.0093	0.0093	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00923	0.00923	CcSEcCtD
Cisatracurium Besylate—Angioedema—Topotecan—ovarian cancer	0.00873	0.00873	CcSEcCtD
Cisatracurium Besylate—Flushing—Vinorelbine—ovarian cancer	0.00871	0.00871	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Paclitaxel—ovarian cancer	0.00868	0.00868	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Vinorelbine—ovarian cancer	0.00852	0.00852	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Vinorelbine—ovarian cancer	0.00848	0.00848	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00846	0.00846	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Epirubicin—ovarian cancer	0.00818	0.00818	CcSEcCtD
Cisatracurium Besylate—Erythema—Vinorelbine—ovarian cancer	0.00817	0.00817	CcSEcCtD
Cisatracurium Besylate—Convulsion—Melphalan—ovarian cancer	0.00811	0.00811	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00808	0.00808	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Paclitaxel—ovarian cancer	0.00805	0.00805	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00791	0.00791	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Topotecan—ovarian cancer	0.0078	0.0078	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Topotecan—ovarian cancer	0.00765	0.00765	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Melphalan—ovarian cancer	0.00764	0.00764	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Topotecan—ovarian cancer	0.00757	0.00757	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Doxorubicin—ovarian cancer	0.00757	0.00757	CcSEcCtD
Cisatracurium Besylate—Angioedema—Vinorelbine—ovarian cancer	0.00747	0.00747	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Melphalan—ovarian cancer	0.00745	0.00745	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Melphalan—ovarian cancer	0.00742	0.00742	CcSEcCtD
Cisatracurium Besylate—Hypotension—Melphalan—ovarian cancer	0.00713	0.00713	CcSEcCtD
Cisatracurium Besylate—Hypertension—Vinorelbine—ovarian cancer	0.00706	0.00706	CcSEcCtD
Cisatracurium Besylate—Urticaria—Chlorambucil—ovarian cancer	0.00696	0.00696	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Topotecan—ovarian cancer	0.00695	0.00695	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00691	0.00691	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Melphalan—ovarian cancer	0.00681	0.00681	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00667	0.00667	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Docetaxel—ovarian cancer	0.00658	0.00658	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Vinorelbine—ovarian cancer	0.00654	0.00654	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Vinorelbine—ovarian cancer	0.00651	0.00651	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Vinorelbine—ovarian cancer	0.00648	0.00648	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00645	0.00645	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Paclitaxel—ovarian cancer	0.00643	0.00643	CcSEcCtD
Cisatracurium Besylate—Hypotension—Vinorelbine—ovarian cancer	0.00623	0.00623	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00621	0.00621	CcSEcCtD
Cisatracurium Besylate—Pruritus—Chlorambucil—ovarian cancer	0.0062	0.0062	CcSEcCtD
Cisatracurium Besylate—Urticaria—Topotecan—ovarian cancer	0.00619	0.00619	CcSEcCtD
Cisatracurium Besylate—Urticaria—Melphalan—ovarian cancer	0.00607	0.00607	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Vinorelbine—ovarian cancer	0.00595	0.00595	CcSEcCtD
Cisatracurium Besylate—Flushing—Paclitaxel—ovarian cancer	0.00586	0.00586	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Topotecan—ovarian cancer	0.00575	0.00575	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Paclitaxel—ovarian cancer	0.00573	0.00573	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Paclitaxel—ovarian cancer	0.0057	0.0057	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00569	0.00569	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Melphalan—ovarian cancer	0.00563	0.00563	CcSEcCtD
Cisatracurium Besylate—Pruritus—Topotecan—ovarian cancer	0.00552	0.00552	CcSEcCtD
Cisatracurium Besylate—Erythema—Paclitaxel—ovarian cancer	0.0055	0.0055	CcSEcCtD
Cisatracurium Besylate—Pruritus—Melphalan—ovarian cancer	0.0054	0.0054	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00539	0.00539	CcSEcCtD
Cisatracurium Besylate—Urticaria—Vinorelbine—ovarian cancer	0.0053	0.0053	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Docetaxel—ovarian cancer	0.00526	0.00526	CcSEcCtD
Cisatracurium Besylate—Angioedema—Paclitaxel—ovarian cancer	0.00502	0.00502	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00499	0.00499	CcSEcCtD
Cisatracurium Besylate—Flushing—Docetaxel—ovarian cancer	0.00497	0.00497	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Epirubicin—ovarian cancer	0.00496	0.00496	CcSEcCtD
Cisatracurium Besylate—Rash—Topotecan—ovarian cancer	0.00492	0.00492	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00491	0.00491	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Topotecan—ovarian cancer	0.00491	0.00491	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Docetaxel—ovarian cancer	0.00486	0.00486	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Docetaxel—ovarian cancer	0.00484	0.00484	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Docetaxel—ovarian cancer	0.00482	0.00482	CcSEcCtD
Cisatracurium Besylate—Rash—Melphalan—ovarian cancer	0.00481	0.00481	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Melphalan—ovarian cancer	0.00481	0.00481	CcSEcCtD
Cisatracurium Besylate—Convulsion—Paclitaxel—ovarian cancer	0.00476	0.00476	CcSEcCtD
Cisatracurium Besylate—Hypertension—Paclitaxel—ovarian cancer	0.00475	0.00475	CcSEcCtD
Cisatracurium Besylate—Pruritus—Vinorelbine—ovarian cancer	0.00472	0.00472	CcSEcCtD
Cisatracurium Besylate—Erythema—Docetaxel—ovarian cancer	0.00466	0.00466	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00465	0.00465	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Epirubicin—ovarian cancer	0.0046	0.0046	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Doxorubicin—ovarian cancer	0.00459	0.00459	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00449	0.00449	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Paclitaxel—ovarian cancer	0.0044	0.0044	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Paclitaxel—ovarian cancer	0.00438	0.00438	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Paclitaxel—ovarian cancer	0.00436	0.00436	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Doxorubicin—ovarian cancer	0.00426	0.00426	CcSEcCtD
Cisatracurium Besylate—Rash—Vinorelbine—ovarian cancer	0.00421	0.00421	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Vinorelbine—ovarian cancer	0.0042	0.0042	CcSEcCtD
Cisatracurium Besylate—Hypotension—Paclitaxel—ovarian cancer	0.00419	0.00419	CcSEcCtD
Cisatracurium Besylate—Convulsion—Docetaxel—ovarian cancer	0.00404	0.00404	CcSEcCtD
Cisatracurium Besylate—Hypertension—Docetaxel—ovarian cancer	0.00402	0.00402	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Paclitaxel—ovarian cancer	0.004	0.004	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00394	0.00394	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Docetaxel—ovarian cancer	0.0038	0.0038	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Docetaxel—ovarian cancer	0.00373	0.00373	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Docetaxel—ovarian cancer	0.00371	0.00371	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Docetaxel—ovarian cancer	0.00369	0.00369	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Epirubicin—ovarian cancer	0.00368	0.00368	CcSEcCtD
Cisatracurium Besylate—Urticaria—Paclitaxel—ovarian cancer	0.00356	0.00356	CcSEcCtD
Cisatracurium Besylate—Hypotension—Docetaxel—ovarian cancer	0.00355	0.00355	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Epirubicin—ovarian cancer	0.00355	0.00355	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Doxorubicin—ovarian cancer	0.0034	0.0034	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Docetaxel—ovarian cancer	0.00339	0.00339	CcSEcCtD
Cisatracurium Besylate—Flushing—Epirubicin—ovarian cancer	0.00335	0.00335	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00331	0.00331	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00328	0.00328	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Epirubicin—ovarian cancer	0.00328	0.00328	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Epirubicin—ovarian cancer	0.00326	0.00326	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Epirubicin—ovarian cancer	0.00325	0.00325	CcSEcCtD
Cisatracurium Besylate—Pruritus—Paclitaxel—ovarian cancer	0.00317	0.00317	CcSEcCtD
Cisatracurium Besylate—Erythema—Epirubicin—ovarian cancer	0.00314	0.00314	CcSEcCtD
Cisatracurium Besylate—Flushing—Doxorubicin—ovarian cancer	0.0031	0.0031	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Doxorubicin—ovarian cancer	0.00303	0.00303	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Doxorubicin—ovarian cancer	0.00302	0.00302	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00301	0.00301	CcSEcCtD
Cisatracurium Besylate—Erythema—Doxorubicin—ovarian cancer	0.00291	0.00291	CcSEcCtD
Cisatracurium Besylate—Rash—Paclitaxel—ovarian cancer	0.00283	0.00283	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Paclitaxel—ovarian cancer	0.00283	0.00283	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Docetaxel—ovarian cancer	0.0028	0.0028	CcSEcCtD
Cisatracurium Besylate—Convulsion—Epirubicin—ovarian cancer	0.00272	0.00272	CcSEcCtD
Cisatracurium Besylate—Hypertension—Epirubicin—ovarian cancer	0.00271	0.00271	CcSEcCtD
Cisatracurium Besylate—Pruritus—Docetaxel—ovarian cancer	0.00269	0.00269	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00266	0.00266	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Epirubicin—ovarian cancer	0.00257	0.00257	CcSEcCtD
Cisatracurium Besylate—Convulsion—Doxorubicin—ovarian cancer	0.00252	0.00252	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Epirubicin—ovarian cancer	0.00252	0.00252	CcSEcCtD
Cisatracurium Besylate—Hypertension—Doxorubicin—ovarian cancer	0.00251	0.00251	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Epirubicin—ovarian cancer	0.0025	0.0025	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Epirubicin—ovarian cancer	0.00249	0.00249	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00246	0.00246	CcSEcCtD
Cisatracurium Besylate—Rash—Docetaxel—ovarian cancer	0.0024	0.0024	CcSEcCtD
Cisatracurium Besylate—Hypotension—Epirubicin—ovarian cancer	0.0024	0.0024	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Docetaxel—ovarian cancer	0.0024	0.0024	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00237	0.00237	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Doxorubicin—ovarian cancer	0.00233	0.00233	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Doxorubicin—ovarian cancer	0.00232	0.00232	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Doxorubicin—ovarian cancer	0.00231	0.00231	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Epirubicin—ovarian cancer	0.00229	0.00229	CcSEcCtD
Cisatracurium Besylate—Hypotension—Doxorubicin—ovarian cancer	0.00222	0.00222	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Doxorubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Cisatracurium Besylate—Urticaria—Epirubicin—ovarian cancer	0.00204	0.00204	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Epirubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Cisatracurium Besylate—Urticaria—Doxorubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Cisatracurium Besylate—Pruritus—Epirubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Doxorubicin—ovarian cancer	0.00175	0.00175	CcSEcCtD
Cisatracurium Besylate—Pruritus—Doxorubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Cisatracurium Besylate—Rash—Epirubicin—ovarian cancer	0.00162	0.00162	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Epirubicin—ovarian cancer	0.00162	0.00162	CcSEcCtD
Cisatracurium Besylate—Rash—Doxorubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Doxorubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
